NCT03629886 2024-03-15
Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
Phase 4 Completed
GlaxoSmithKline
Xiamen Innovax Biotech Co., Ltd
GlaxoSmithKline
University Hospital, Geneva